Advanced Biomed Inc. financial data

Symbol
ADVB on Nasdaq
Location
401 Ryland St, Ste 200 A, Reno, NV
Latest financial report
10-Q - Q3 2025 - Nov 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 164 %
Debt-to-equity 127 %
Return On Equity -120 %
Return On Assets -52.9 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.6M shares
Common Stock, Shares, Outstanding 21.6M shares -78.4%
Entity Public Float 4.43M USD
Common Stock, Value, Issued 21.6K USD
Weighted Average Number of Shares Outstanding, Basic 21.6M shares +8.2%
Weighted Average Number of Shares Outstanding, Diluted 21.6M shares +8.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 964K USD +29.9%
General and Administrative Expense 2.06M USD -14.9%
Nonoperating Income (Expense) -355K USD -46.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.38M USD -45.7%
Net Income (Loss) Attributable to Parent -3.38M USD -45.7%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 5.84M USD
Property, Plant and Equipment, Net 281K USD
Operating Lease, Right-of-Use Asset 42.8K USD
Other Assets, Noncurrent 74.8K USD
Assets 6.24M USD
Accounts Payable, Current 642K USD
Liabilities, Current 3.04M USD
Operating Lease, Liability, Noncurrent 2.94K USD
Liabilities 3.24M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.26M USD
Retained Earnings (Accumulated Deficit) -19.6M USD
Stockholders' Equity Attributable to Parent 3M USD +175%
Liabilities and Equity 6.24M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -610K USD -1956%
Net Cash Provided by (Used in) Financing Activities 447K USD +14%
Net Cash Provided by (Used in) Investing Activities -1.77K USD +91.1%
Common Stock, Shares Authorized 400M shares
Common Stock, Shares, Issued 21.6M shares -78.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -247K USD -734%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.66M USD +0.36%
Deferred Tax Assets, Valuation Allowance 2.93M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 30.9K USD
Depreciation 206K USD -28.7%
Payments to Acquire Property, Plant, and Equipment 1.77K USD -91.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.94M USD +16.9%
Lessee, Operating Lease, Liability, to be Paid 31.3K USD
Property, Plant and Equipment, Gross 1.85M USD
Operating Lease, Liability, Current 27.9K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.93K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 5.68K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 451 USD
Deferred Tax Assets, Operating Loss Carryforwards 2.93M USD
Amortization of Intangible Assets 30.2K USD -5.35%